Zaid S Al-Kadhimi
Overview
Explore the profile of Zaid S Al-Kadhimi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhatt V, Wichman C, Al-Kadhimi Z, Koll T, Fisher A, Mahato R, et al.
J Geriatr Oncol
. 2022 Apr;
13(6):871-874.
PMID: 35450817
Introduction: Survival benefit associated with intensive over low-intensity chemotherapy in older adults with acute myeloid leukemia (AML) is controversial. Geriatric assessment and genetic risk categories correlate with survival following intensive...
2.
Gundabolu K, Dave B, Alvares C, Cannatella J, Bhatt V, Maness L, et al.
Case Rep Genet
. 2022 Mar;
2022:6977041.
PMID: 35281324
Chronic myelomonocytic leukemia (CMML) is a rare but distinct hematological neoplasm with overlapping features of myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN). Individuals with CMML have persistent monocytosis and bone...
3.
Kharfan-Dabaja M, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, et al.
Transplant Cell Ther
. 2021 Jul;
27(8):642-649.
PMID: 34304802
Allogeneic hematopoietic cell transplantation (allo-HCT) is potentially curative for certain hematologic malignancies and nonmalignant diseases. The field of allo-HCT has witnessed significant advances, including broadening indications for transplantation, availability of...
4.
Dhakal P, Shostrom V, Al-Kadhimi Z, Maness L, Gundabolu K, Bhatt V
Clin Lymphoma Myeloma Leuk
. 2020 Aug;
20(12):804-812.e8.
PMID: 32739312
Introduction: Older adults with acute myeloid leukemia (AML) often have significant comorbidities. We hypothesized that greater comorbidity burden predicts worse 1-month mortality and overall survival (OS) in patients ≥60 years...
5.
Dhakal P, Lyden E, Muir K, Al-Kadhimi Z, Maness L, Gundabolu K, et al.
Clin Lymphoma Myeloma Leuk
. 2020 Jul;
20(10):e685-e690.
PMID: 32660903
Introduction: Patients living farther away from academic centers may not have easy access to resources for management of acute myeloid leukemia (AML). We aimed to analyze the effect of distance...
6.
Dhakal P, Lyden E, Muir K, Al-Kadhimi Z, Koll T, Maness L, et al.
Leuk Lymphoma
. 2020 Mar;
61(7):1702-1708.
PMID: 32157936
Polypharmacy, usually defined as taking ≥5 prescribed medications, increases chances of drug-drug interactions and toxicities, and may harm cancer patients who need multiple chemotherapeutic agents and supportive medications. We analyzed...
7.
Bhatt V, Shostrom V, Holstein S, Al-Kadhimi Z, Maness L, Berger A, et al.
Clin Lymphoma Myeloma Leuk
. 2020 Mar;
20(5):e239-e258.
PMID: 32111572
Background: Controversy exists regarding the optimal chemotherapy regimen for older adults with acute myeloid leukemia (AML). Patients And Methods: We analyzed data from the US National Cancer Data Base of...
8.
Dhakal P, Lyden E, Lee A, Michalski J, Al-Kadhimi Z, Maness L, et al.
Clin Lymphoma Myeloma Leuk
. 2020 Feb;
20(3):e131-e136.
PMID: 32029396
Background: The role of obesity in prognosis of acute myeloid leukemia (AML) is debatable. Our retrospective study aimed to determine the effect of obesity on overall survival (OS) in AML....
9.
Michalski J, Lyden E, Lee A, Al-Kadhimi Z, Maness L, Gundabolu K, et al.
Future Oncol
. 2019 Jun;
15(17):1989-1995.
PMID: 31170814
This study evaluated the overall survival (OS) of older patients (≥60 years) with acute myeloid leukemia based on the intensity of treatment. This single center, retrospective study included 211 patients...